Anti-TNF-α (infliximab) therapy for severe adult eosinophilic esophagitis

Journal of Allergy and Clinical Immunology

Volumn 122, Issue 2, 2008, Pages 425-427

  Straumann, Alex ^a   Bussmann, Christian ^b   Conus, Sébastien ^c   Beglinger, Christoph ^d   Simon, Hans Uwe ^c  

^a Kantonsspital ^*  (Switzerland)

^b Pathology Viollier   (Switzerland)

^c UNIVERSITY OF BERN   (Switzerland)

^d UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; EOTAXIN 3; FLUTICASONE; INFLIXIMAB; PREDNISONE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; CASE REPORT; CELL INFILTRATION; CYTOKINE RELEASE; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG WITHDRAWAL; EOSINOPHIL; EOSINOPHILIC ESOPHAGITIS; ESOPHAGUS MUCOSA; HUMAN; LETTER; MAINTENANCE THERAPY; MALE; MONOTHERAPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT DISEASE; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ADULT; ANTIBODIES, MONOCLONAL; EOSINOPHILS; EPITHELIAL CELLS; ESOPHAGITIS; ESOPHAGUS; HUMANS; LEUKOCYTE COUNT; MALE; PILOT PROJECTS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 48249091585     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2008.06.012     Document Type: Letter

References (9)

1. Straumann A., Spichtin H.P., Grize L., Bucher K.A., Beglinger C., and Simon H.U. Natural history of primary eosinophilic esophagitis: a follow-up of 30 adult patients for up to 11.5 years. Gastroenterology 125 (2003) 1660-1669
2. Noel R.J., Putnam P.E., and Rothenberg M.E. Eosinophilic esophagitis. N Engl J Med 351 (2004) 940-941
3. Straumann A., and Simon H.U. Eosinophilic esophagitis: escalating epidemiology?. J Allergy Clin Immunol 115 (2005) 418-419
4. Furuta G.T., Liacouras C.A., Collins M.H., Gupta S.K., Justinich C., Putnam P.E., et al. First International Gastrointestinal Eosinophil Research Symposium (FIGERS) Subcommittees. Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology 133 (2007) 1342-1363
5. Straumann A., Bauer M., Fischer B., Blaser K., and Simon H.U. Idiopathic eosinophilic esophagitis is associated with a Th2-type allergic inflammatory response. J Allergy Clin Immunol 108 (2001) 954-961
6. Blanchard C., Wang N., Stringer K.F., Mishra A., Fulkerson P.C., Abonia J.P., et al. Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. J Clin Invest 116 (2006) 536-547
7. Targan S.R., Hanauer S.B., van Deventer S.J., Mayer L., Present D.H., Braakman T., et al. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's disease cA2 Study Group. N Engl J Med 337 (1997) 1029-1035
8. Elliott M.J., Maini R.N., Feldmann M., Kalden J.R., Antoni C., Smolen J.S., et al. Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis. Lancet 344 (1994) 1105-1110
9. Erin E.M., Leaker B.R., Nicholson G.C., Tan A.J., Green L.M., Neighbour H., et al. The effects of a monoclonal antibody directed against tumor necrosis factor-alpha in asthma. Am J Respir Crit Care Med 174 (2006) 753-762